Basel, 16 September 2020
Invitation to Roche's 3rd Quarter Sales 2020 Webinar
Roche will publish its Sales Results for the 3rd Quarter of 2020 prior to the opening of the Swiss Stock Exchange on Thursday, October 15th, 2020.
07:00 CEST / 06:00 BST / 01:00 AM EDT / 10:00 PM PDT (evening before)
Release will be e-mailed and posted on the Roche IR website click here
Presentation slides will be posted on the Roche IR website click here
14:00 - 15:15 CEST / 13:00 - 14:15 BST
08:00 - 09:15 AM EDT / 05:00 - 06:15 AM PDT
The webinar will start with presentations by senior management, followed by a Q&A session.
Presenters:
- Severin Schwan, CEO Roche Group
- Bill Anderson, CEO Roche Pharmaceuticals
- Thomas Schinecker, CEO Roche Diagnostics
- Alan Hippe, Chief Financial and IT Officer
We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*
A replay of the webcast will be available via ir.roche.com
*privacy notice
Best regards, | |
Karl Mahler Head of Investor Relations | |
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber Phone: +41 61 68-88027 e-mail: sabine.borngraeber@roche.com |
Dr. Bruno Eschli Phone: +41 61 68-75284 e-mail: bruno.eschli@roche.com |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 16 September 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 16 September 2020 08:04:03 UTC